MedMira increases global sales team

By Elaine Rigoli

Tampa, Fla., June 29 - MedMira, Inc. said it has expanded its global sales presence in the European/Middle Eastern, Latin American and Asian markets to capitalize on market penetration opportunities from recently completed key regulatory approvals.

After receiving CE Mark in early 2006 for its MiraCare rapid HIV antibody test, the company said it selected countries in which to register with the Competent Authority, governing bodies within each member country regulating the sale of medical devices.

MedMira's regulatory team has completed 13 registrations, the final step in the regulatory process, and will continue to pursue registrations in strategic country markets where sales opportunities exist, according to a news release.

In Asia, MedMira has engaged MediServe, Inc. to head the company's sales and marketing in that region. MediServe, a consulting group, is a partnership of project managers, medical doctors and health care practitioners, the release said.

In April, MedMira received a fast-track approval for the first whole blood rapid HIV test available in China.

This approval enables MediServe to capitalize on a key competitive advantage for MedMira in the China market, the release said.

Based in Halifax, Nova Scotia, MedMira develops in-vitro flow-through rapid diagnostic tests.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.